China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Decrease in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 67,000 shares, a decline of 36.4% from the October 31st total of 105,300 shares. Based on an average trading volume of 587,700 shares, the short-interest ratio is currently 0.1 days. Currently, 2.0% of the shares of the stock are sold short.

China SXT Pharmaceuticals Price Performance

Shares of SXTC traded up $0.01 during mid-day trading on Thursday, hitting $0.41. 182,559 shares of the company traded hands, compared to its average volume of 718,647. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.60 and a quick ratio of 1.51. The business has a 50-day moving average of $0.56 and a 200 day moving average of $0.84. China SXT Pharmaceuticals has a one year low of $0.37 and a one year high of $6.39.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.